John W Moore1, Robert N Vincent2, Robert H Beekman3, Lee Benson4, Lisa Bergersen5, Ralf Holzer6, Natalie Jayaram7, Kathy Jenkins5, Yan Li8, Richard Ringel9, Jonathan Rome10, Gerard R Martin11. 1. Division of Cardiology, Department of Pediatrics, Rady Children's Hospital, University of California-San Diego, San Diego, California. Electronic address: jmoore@rchsd.org. 2. Division of Cardiology, Department of Pediatrics, Children's Healthcare of Atlanta, Emory University, Atlanta, Georgia. 3. Division of Cardiology, Department of Pediatrics, Cincinnati Children's Hospital Medical Center, University of Cincinnati, Cincinnati, Ohio. 4. Division of Cardiology, Department of Pediatrics, Toronto Hospital for Sick Children, University of Toronto, Toronto, Ontario, Canada. 5. Department of Cardiology, Boston Children's Hospital, Harvard University, Boston, Massachusetts. 6. Division of Cardiology, Department of Pediatrics, Nationwide Children's Hospital, Ohio State University College of Medicine, Columbus, Ohio. 7. Division of Cardiology, Department of Pediatrics, Children's Mercy Hospitals and Clinics, Kansas City, Missouri; Saint Luke's Mid America Heart Institute, Kansas City, Missouri. 8. Saint Luke's Mid America Heart Institute, Kansas City, Missouri. 9. Division of Cardiology, Department of Pediatrics, Johns Hopkins Children's Center, Johns Hopkins University, Baltimore, Maryland. 10. Children's Hospital of Philadelphia, University of Pennsylvania, Philadelphia, Pennsylvania. 11. Children's National Health System, George Washington University, Washington, DC.
Abstract
BACKGROUND: The National Cardiovascular Data Registry (NCDR) launched the IMPACT (Improving Pediatric and Adult Congenital Treatment) Registry in 2010. By 2013, its patient enrollment exceeded that of other current and historical congenital catheterization registries. OBJECTIVES: This study sought to describe procedural results and safety of 6 common congenital interventions performed in patients enrolled during the IMPACT Registry's initial periods. METHODS: With specified exclusions, we compiled registry data from patients enrolled in the IMPACT Registry from January 2011 through March 2013 who underwent 1 of the following isolated procedures: device closure of atrial septal defect (ASD); device closure of patent ductus arteriosus (PDA); pulmonary valvuloplasty; aortic valvuloplasty; coarctation of the aorta angioplasty and stenting; and pulmonary artery stenting. Patient data, procedural data and results, and adverse events (AEs) were reviewed and described. RESULTS: In 4,152 catheterizations, 1 isolated procedure was reported. There were 1,286 single-ASD procedures, 1,375 PDA procedures, 270 "typical" pulmonary valve procedures, 305 aortic valve procedures, 671 aortic procedures, and 245 pulmonary artery procedures. The reported procedure was performed in >95% of catheterizations. Stated outcomes were accomplished in >98% of ASD and PDA procedures, but less commonly in the others, with coarctation angioplasty procedures being the least successful (51%). Reported major AE rates ranged from 0% to 3.3%; total AE rates ranged from 5.3% to 24.3%. CONCLUSIONS: Contemporary community practice, procedural outcomes, and safety for 6 common congenital interventional procedures are reported. These benchmarks may be compared with individual center results and historical single-center and multicenter results.
BACKGROUND: The National Cardiovascular Data Registry (NCDR) launched the IMPACT (Improving Pediatric and Adult Congenital Treatment) Registry in 2010. By 2013, its patient enrollment exceeded that of other current and historical congenital catheterization registries. OBJECTIVES: This study sought to describe procedural results and safety of 6 common congenital interventions performed in patients enrolled during the IMPACT Registry's initial periods. METHODS: With specified exclusions, we compiled registry data from patients enrolled in the IMPACT Registry from January 2011 through March 2013 who underwent 1 of the following isolated procedures: device closure of atrial septal defect (ASD); device closure of patent ductus arteriosus (PDA); pulmonary valvuloplasty; aortic valvuloplasty; coarctation of the aorta angioplasty and stenting; and pulmonary artery stenting. Patient data, procedural data and results, and adverse events (AEs) were reviewed and described. RESULTS: In 4,152 catheterizations, 1 isolated procedure was reported. There were 1,286 single-ASD procedures, 1,375 PDA procedures, 270 "typical" pulmonary valve procedures, 305 aortic valve procedures, 671 aortic procedures, and 245 pulmonary artery procedures. The reported procedure was performed in >95% of catheterizations. Stated outcomes were accomplished in >98% of ASD and PDA procedures, but less commonly in the others, with coarctation angioplasty procedures being the least successful (51%). Reported major AE rates ranged from 0% to 3.3%; total AE rates ranged from 5.3% to 24.3%. CONCLUSIONS: Contemporary community practice, procedural outcomes, and safety for 6 common congenital interventional procedures are reported. These benchmarks may be compared with individual center results and historical single-center and multicenter results.
Authors: Michael L O'Byrne; Russell T Shinohara; Elena K Grant; Joshua P Kanter; Matthew J Gillespie; Yoav Dori; Jonathan J Rome; Andrew C Glatz Journal: Am Heart J Date: 2017-07-19 Impact factor: 4.749
Authors: Michael L O'Byrne; Matthew J Gillespie; Kevin F Kennedy; Yoav Dori; Jonathan J Rome; Andrew C Glatz Journal: Catheter Cardiovasc Interv Date: 2016-05-18 Impact factor: 2.692